Evidence map›Paper›PMID 34515276›Full record

ArticleChemical communications (Cambridge, England)2021

Catalytic atroposelective dynamic kinetic resolutions and kinetic resolutions towards 3-arylquinolines

Mariel M Cardenas, Mirza A Saputra, Deane A Gordon, Andrea N Sanchez, Nobuyuki Yamamoto, Jeffrey L Gustafson

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical communications (Cambridge, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Atropisomerism in the Pharmaceutically Relevant Realm.Accounts of chemical research · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mariel M CardenasCollege of Sciences, Department of Chemistry and Biochemistry, San Diego State University, 5500 Campanile Drive, San Diego, California, 92182-1030, USA. JGustafson@sdsu.edu.
Mirza A SaputraCollege of Sciences, Department of Chemistry and Biochemistry, San Diego State University, 5500 Campanile Drive, San Diego, California, 92182-1030, USA. JGustafson@sdsu.edu.
Deane A GordonCollege of Sciences, Department of Chemistry and Biochemistry, San Diego State University, 5500 Campanile Drive, San Diego, California, 92182-1030, USA. JGustafson@sdsu.edu.
Andrea N SanchezCollege of Sciences, Department of Chemistry and Biochemistry, San Diego State University, 5500 Campanile Drive, San Diego, California, 92182-1030, USA. JGustafson@sdsu.edu.
Nobuyuki YamamotoCollege of Sciences, Department of Chemistry and Biochemistry, San Diego State University, 5500 Campanile Drive, San Diego, California, 92182-1030, USA. JGustafson@sdsu.edu.
Jeffrey L GustafsonCollege of Sciences, Department of Chemistry and Biochemistry, San Diego State University, 5500 Campanile Drive, San Diego, California, 92182-1030, USA. JGustafson@sdsu.edu.ORCID http://orcid.org/0000-0001-7054-7595
San Diego State University · US

Funding

MIRA: Atropisomerism as an inspiration for drug discovery and new chemistryR35GM124637 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI Jeffrey Louis Gustafson · 2017 to 2026
$3.8M
NIGMS NIH HHS R35 GM124637
6 · The paper itself

Abstract

Herein we report the catalytic atroposelective syntheses of pharmaceutically relevant 3-arylquinolines

Identifiers

PMID34515276
PMCPMC9799074
OpenAlexW3197926059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.